search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • Print
  • ShareThis
  • Text Size

"Guidelines for Preventing Infections Complications Among Hematopoietic Cell Transplantation Recipients: A Global Perspective" (Endorsed by IDSA)

currentendorsed
Published: Biol Blood Marrow Transplant ; 2009 ; 15 : 1143 -1238

Abstract

In the past decade, modifications in HCT management and supportive care have resulted in changes in recommendations for the prevention of infection in HCT patients. These changes are fueled by new antimicrobial agents, increased knowledge of immune reconstitution, and expanded conditioning regimens and patient populations eligible for HCT. Despite these advances, infection is reported as the primary cause of death in 8% of autologous HCT patients and 17% to 20% of allogeneic HCT recipients [3]. The major changes in this document, including changes in recommendation ratings, are summarized here.

 

*For information on the timing of future updates to this guideline, contact CIBMTR.

Recommendations

For information on the recommendations of this guideline, please visit the following link

Additional Resources

*For information on additional resources, please contact CIBMTR.

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site